Author

Franziska Faber

University of WürzburgORCID 0000-0002-8700-6522Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:C. elegans· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:clustering· 1

Frequent Co-Authors

Johannes SulzeriD· 2 shared Till StrowigiD· 2 shared Arne BublitziD· 1 shared Bastian MolitoriD· 1 shared Claire E. TurneriD· 1 shared Janet WackenreuteriD· 1 shared Jessica E. BuddleiD· 1 shared Jörg VogeliD· 1 shared

Activity by Year

2023-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Johannes SulzerORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

ASO-mediated mRNA silencing enables functional analysis and selective depletion of the human microbiota Prevotellaceae

Valentina Cosi, Vincent Lau, Petia Kovatcheva‐Datchary, Youssef El Mouali, Toby Wilkinson, Victoria Gebler, Linda Popella, Franziska Faber, Till Strowig, Jörg Vogel

This study uses ASOs to selectively inhibit mRNA translation in Prevotellaceae species, enabling functional analysis and targeted depletion in synthetic communities.

bioRxiv · Apr 18, 2026 · PreprintMicrobiology

A novel two-component system controls vancomycin resistance in epidemic Clostridioides difficile

Jessica E. Buddle, Victoria K Pennington, Joseph A. Kirk, Franziska Faber, Claire E. Turner, Michael A. Brockhurst, Robert P. Fagan

This paper identifies two point mutations in a two-component system that confer vancomycin resistance in C. difficile, revealing a synergistic pathway for resistance in epidemic strains.

bioRxiv · Aug 21, 2025 · PreprintMicrobiology

Proton-pump inhibitors increase C. difficile infection risk by altering pH rather than by affecting the gut microbiome based on a bioreactor model

Julia Schumacher, Patrick Müller, Johannes Sulzer, Franziska Faber, Bastian Molitor, Lisa Maier

Gut Microbes · Jun 16, 2025Peer-reviewedMicrobiology

A network of small RNAs regulates sporulation initiation in C. difficile

Manuela Fuchs, Vanessa Lamm‐Schmidt, Tina Lenče, Johannes Sulzer, Arne Bublitz, Janet Wackenreuter, Milan Gerovac, Till Strowig, Franziska Faber

The paper identifies a network of small RNAs that regulate sporulation in C. difficile by modulating translation of the master sporulation regulator Spo0A.

The EMBO Journal · May 4, 2023Peer-reviewedMolecular Biology